A-Alpha Bio will build lab space in downtown Seattle and beef up its machine learning…
dcorriganSeptember 10, 2021
Unlike healthy livers, those damaged by disorders like cirrhosis have difficulty repairing themselves. The regenerative…
dcorriganSeptember 9, 2021
Big data, artificial intelligence and machine learning are becoming increasingly important to drug developers. With…
dcorriganSeptember 9, 2021
Researchers from Institute for Systems Biology (ISB), Fred Hutchinson Cancer Research Center and other organizations…
dcorriganSeptember 8, 2021
A device that could make it possible for patients to draw their own blood at…
dcorriganSeptember 7, 2021
The U.S. Food and Drug Administration has approved Impel NeuroPharma’s Trudhesa to treat migraine headaches, the Seattle…
dcorriganSeptember 7, 2021
Early research shows current FDA-approved drugs might be repurposed to calm COVID-19’s deadly cytokine storms…
dcorriganSeptember 6, 2021
Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced…
dcorriganSeptember 3, 2021
The gleaming skyscrapers towering along Park Avenue always seemed opaque and out of reach to Dr.…
dcorriganSeptember 3, 2021
